Ca 15-3 in the follow-up of localised breast cancer: a prospective study

This publication has 10 references indexed in Scilit:

• CA27.29: a valuable marker for breast cancer management. A confirmatory multicentric study on 603 cases
  European Journal Of Cancer, 2001
• The objective measurement of remission and progression in metastatic breast cancer by use of serum tumour markers
  European Journal Of Cancer, 1999
• Recommended breast cancer surveillance guidelines. American Society of Clinical Oncology.
  Journal of Clinical Oncology, 1997
• Relationship between CA 15-3 serum levels and disease extent in predicting overall survival of breast cancer patients with newly diagnosed metastatic disease
  British Journal of Cancer, 1997
• Tumor markers in breast cancer follow-up: A potentially useful parameter still awaiting definitive assessment
  Annals of Oncology, 1995
• Prognostic value in predicting overall survival of two mucinous markers: CA 15-3 and CA 125 in breast cancer patients at first relapse of disease
  European Journal Of Cancer, 1994
• CA 15.3 determination in patients with breast cancer: Clinical utility for the detection of distant metastases
  European Journal Of Cancer, 1993
• A novel method for monitoring high-risk breast cancer with tumor markers: CA 15.3 compared to CEA and TPA
  Annals of Oncology, 1993
• CA 15-3 in patients with locoregional and metastatic breast carcinoma
  Cancer, 1992
• CA 15-3 and carcinoembryonic antigen in the clinical evaluation of breast cancer
  Clinica Chimica Acta; International Journal of Clinical Chemistry, 1991